30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kristine Peterson

Positions

Position Company Period
Independent Director ImmunoGen Inc Jan. 30, 2012 -
Independent Director Paratek Pharmaceuticals Inc March 2, 2016 -
Independent Director EyePoint Inc June 28, 2017 -
Independent Director Enanta Pharmaceuticals Inc Sept. 11, 2017 -
Non-Executive Independent Director Amarin Corporation PLC Nov. 18, 2010 -
Chief Executive Officer Valeritas Holdings Inc None -

Kristine Peterson's trades of ImmunoGen Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-12-05 2023-11-30 PlS Planned sale
59,437 -28.3%
109.95
US$1,639,410
59,437 -28.3% 109.95 US$1,639,410
2023-11-30 2023-11-30 PrS Proposed sale
67,965
167.89
US$2,177,369
67,965 167.89 US$2,177,369
2023-09-13 2023-09-13 PrS Proposed sale
80,643
116.98
US$1,730,504
80,643 116.98 US$1,730,504
2019-02-22 2019-02-22 PlS Planned sale
163,500 -100.0%
20.02
US$3,274,038
163,500 -100.0% 20.02 US$3,274,038